Systematic review and meta-analysis of the prognostic significance of CpG Island Methylator Phenotype in gastric cancer

Author(s):  
Arfon Powell
2018 ◽  
Vol 11 (5) ◽  
pp. 1188-1201 ◽  
Author(s):  
Shailesh M. Advani ◽  
Pragati Advani ◽  
Stacia M. DeSantis ◽  
Derek Brown ◽  
Helena M. VonVille ◽  
...  

2018 ◽  
Vol 105 (2) ◽  
pp. e61-e68 ◽  
Author(s):  
A. G. M. T. Powell ◽  
S. Soul ◽  
A. Christian ◽  
W. G. Lewis

Tumor Biology ◽  
2016 ◽  
Vol 37 (8) ◽  
pp. 10675-10684 ◽  
Author(s):  
Young Wha Koh ◽  
Sung-Min Chun ◽  
Young-Soo Park ◽  
Joon Seon Song ◽  
Geon Kook Lee ◽  
...  

2018 ◽  
Vol 33 (8) ◽  
pp. 995-1000 ◽  
Author(s):  
R. F. Kokelaar ◽  
H. Jones ◽  
J. Beynon ◽  
M. E. Evans ◽  
D. A. Harris

Epigenomics ◽  
2019 ◽  
Vol 11 (15) ◽  
pp. 1651-1659
Author(s):  
Sayumi Tahara ◽  
Tomomitsu Tahara ◽  
Noriyuki Horiguchi ◽  
Masaaki Okubo ◽  
Tsuyoshi Terada ◽  
...  

Aim: To investigate the associations between LINE1 methylation, an indicator for genome-wide hypomethylation, molecular and clinicopathological characteristics of gastric cancer (GC) patients. Patients & methods: LINE1 methylation statuses were examined in paired cancerous, non-neoplastic mucosa from 217 GC and gastric mucosa from separate group of 224 noncancer patients. CpG island methylator phenotype, TP53 and KRAS mutation, MLH1 methylation status and promoter hypermethylation of GC related and H. pylori-related genes were examined. Results: Lower LINE1 methylation was observed in primary GC compared with non-neoplastic gastric mucosa and associated with CpG island methylator phenotype, TP53 mutation, MLH1 methylation and promoter hypermethylation of GC related and H. pylori-related genes. Conclusion: Lower LINE1 methylation correlates specific molecular subtypes and promoter hypermethylation in GC.


2018 ◽  
Vol 109 (8) ◽  
pp. 2623-2625 ◽  
Author(s):  
Huashi Xiao ◽  
Jiaxin Fu ◽  
Masanobu Abe ◽  
Jiafu Ji ◽  
Liang Zong

Sign in / Sign up

Export Citation Format

Share Document